Literature DB >> 28443204

Association of genotypes of rs671 withinALDH2 with risk for gastric cardia adenocarcinoma in the Chinese Han population in high- and low-incidence areas.

Lian-Qun Zhang1,2, Xin Song1, Xue-Ke Zhao1, Jia Huang1, Peng Zhang1, Lu-Wen Wang1, Hui Meng1, Jian-Wei Ku1, Guo-Qiang Kong1, Tao Jiang1, Xin-Min Li1, Xiao-Long Lv1, Teng Ma1, Guo Yuan1, Min-Jie Wu1, Shou-Jia Hu1, Shuang Lv1,3, Tang-Juan Zhang1, Ling-Fen Ji1, Zong-Min Fan1, Neng-Chao Wang2, Yao-Wen Zhang2, Fu-You Zhou2, Li-Dong Wang1.   

Abstract

OBJECTIVE: : This study aimed to determine if gastric cardia adenocarcinoma (GCA) risk was associated with the lys (A or *2) allele at the rs671 (glu504lys) polymorphism within the aldehyde dehydrogenase 2 (ALDH2) gene in a Chinese Han population. We also aimed to investigateALDH2 genotypic distributions between subjects from high- and low-incidence areas for both GCA and esophageal squamous cell carcinoma (ESCC).
METHODS: : We designed a case-control study including 2,686 patients with GCA and 3,675 control subjects from high- and low-incidence areas for both GCA and ESCC in China. TaqMan allele discrimination assay was used to genotype the rs671 polymorphism.χ2 test and binary logistic regression analysis were used to estimate the odds ratios for the development of GCA, and multivariate ordinal logistic regression was used to analyzeALDH2 genotypic distributions among different groups.
RESULTS: : Compared withALDH2*1/*1 homozygotes,ALDH2*1/*2 andALDH2*2/*2 carriers did not increase the risk for GCA in the Chinese Han population (P>0.05). Interestingly, the ratio of homozygous or heterozygousALDH2 *2 carriers in high-incidence areas for both GCA and ESCC was lower than that in low-incidence areas (P<0.001).
CONCLUSIONS: : Genotypes of rs671 atALDH2 may not increase GCA susceptibility in Chinese Han populations. In addition, theALDH2 genotypic distribution differs between Chinese Han populations from high- and low-incidence areas for both GCA and ESCC. Our findings may shed light on the possible genetic mechanism for the dramatic geographic differences of GCA occurrence in China.

Entities:  

Keywords:  ALDH2; Gastric cardia adenocarcinoma; high- and low-incidence areas; rs671

Year:  2017        PMID: 28443204      PMCID: PMC5365177          DOI: 10.20892/j.issn.2095-3941.2016.0089

Source DB:  PubMed          Journal:  Cancer Biol Med        ISSN: 2095-3941            Impact factor:   4.248


Introduction

More than half of gastric cardia cancer cases occur in China[1]. Gastric cardia adenocarcinoma (GCA) is one of the most common malignant diseases and often concurrently occurs with esophageal squamous cell carcinoma (ESCC) in China[2]. GCA bears many similarities to ESCC in terms of common geographic distribution and environmental risk factors, including low-intake of fruits and vegetables, nutritional deficiencies, and human papilloma virus infection[2-6]. These striking similarities suggest that a similar molecular mechanism may be involved in these two cancers. Indeed, a few susceptibility genes have been found in both ESCC and GCA, such asPLCE1,C20orf54[7],P53[8-10],Cyclin D1[8], andPCNA[10]. ALDH2 is the main enzyme responsible for acetaldehyde metabolism[11,12]. The humanALDH2 gene is located at chromosome region 12q24[13]. A single-nucleotide polymorphism (SNP) in exon 12 of theALDH2 gene leads to amino acid change from glutamic acid to lysine at residue 504. The wild-type SNP (rs671) encodes glu (G) allele, which is referred to as theALDH2*1 allele. The variant (504lys) allele (A, formerlyALDH2*2 and 487lys) reduces enzyme activity, which could result in malfunction of acetaldehyde metabolism[14,15]. Previous reports showed that rs671 polymorphism was associated with the risk for ESCC and stomach cancer in Japan[16-18]. However, the relationship between rs671 polymorphism and GCA risk is largely unknown. The incidence of GCA in the high-incidence areas for ESCC is 47.74-fold higher than that of the low-incidence areas in China[19]. Geographic distribution and environmental risk factors may be the reasons for the different incidences of GCA in high- and low-incidence areas for both GCA and ESCC. The genotype frequencies ofALDH2 polymorphism vary among the different ethnic populations[20]. TheALDH2*2 allele has not been observed in Caucasians, Africans, and Southeast Asians, but it is widely present in East Asians[21,22]. In East Asians, theALDH2 allele frequency was also found to be different among Japanese, Koreans, and Chinese[23]. In Chinese, theALDH2*2 allele frequency was lower in some aboriginal Chinese populations (e.g., Ami, Atayal, Bunun, Elunchan, Mongolian, and Paiwan) compared with Chinese Han population[20]. In the Chinese Han population, theALDH2*2 allele frequency is 0.17 to 0.29, the ratio of individuals with heterozygousALDH2*2 is 36% to 44%, and the ratio of individuals with homozygousALDH2*2 accounts for 7% to 8%[24-26]. However, no report was found concerning the genotype distribution ofALDH2 in Chinese Han populations from the high- and low-incidence areas for both GCA and ESCC. The purpose of this study was to investigate the relationship between the risk for GCA and rs671 polymorphism withinALDH2 gene in the Chinese Han population. In addition, we are interested in studying the rs671 genotypic distribution characteristics in Chinese Han populations from the high- and low-incidence areas for both GCA and ESCC.

Materials and methods

Study subjects

A total of 2,686 GCA patients (2,081 males and 605 females with a mean age of 61±9 and 61±9 years, respectively) and 3,675 control subjects (1,866 males and 1,809 females with a mean age of 48±12 and 49±11 years, respectively) from high- and low-incidence areas for both GCA and ESCC in China between 2007 and 2010 were provided by Henan Key Laboratory for Esophageal Cancer Research. TheALDH2 genotypic distributions fit the Hardy-Weinberg equilibrium test in this case-control study (P=0.645;P=0.249). According to our genome-wide association study (GWAS) for ESCC, the enrollment criteria for cases and controls in this study were designed[7]. All cases and controls were Chinese Han residents from matched geographic areas without restriction on age, gender, ethnicity, and risk factor exposures. All cases were confirmed as GCA by pathology, and all controls were enrolled among subjects who underwent standard gastroscopy to eliminate the early GCA and did not have any family history of GCA (including first-, second-, and third-degree relatives). This study corresponded with the ethical standards and the Helsinki Declaration.

Determination of theALDH2 genotype

We analyzed the genotypic distributions of rs671 polymorphism in 2,686 cases and 3,675 normal controls, which were derived from replication of GWAS[7]. Flexi Gene DNA kit (QIAGEN, Germany) was used to extract the Genomic DNA from peripheral blood following the manufacturer’s protocol. TaqMan allele discrimination assay was employed for genotyping of the polymorphism (rs671) using the 7300 real-time polymerase chain reaction system (ABI7300; Applied Biosystems, Foster City, CA, USA).

Statistical analysis

Firstly, the allele frequency was measured by direct counting method and the deviation ofALDH2 genotypic distributions from Hardy-Weinberg equilibrium was analyzed. Secondly, multivariate ordinal logistic regression analyzedALDH2 genotypic distributions between different groups, including gender, age, and area. Lastly, using theχ2-test and binary logistic regression analysis, the odds ratio for GCA was estimated by comparing theALDH2*2/*2 andALDH2*1/*2 genotypes with the homozygous wild-type genotype (ALDH2*1/*1), stratified by gender, age, and area. All analyses were performed using SPSS software (version 19.0, SPSS Inc., Chicago, IL, USA).

Results

ALDH2 genotypic distribution status based on the categories of different subgroups

The differences inALDH2 genotypic distribution status in the categories of different subgroups were evaluated. Univariate analyses showed that the ratio of carriers homozygous or heterozygous forALDH2 *2 in the high-incidence areas for both GCA and ESCC was significantly lower than that in the low-incidence areas (ALDH2 2*2 1.71%vs. 2.04%;ALDH2 1*2 22.83%vs. 27.02%,P<0.001).ALDH2 genotypic distribution had no differences in gender, age, or group. Furthermore, this finding was consistent with the results of multivariate analysis ( ).
1

Distribution of the clinical variables according to theALDH2 genotype,n (%)

ItemALDH2*2/*2 ALDH2*1/*2 ALDH2*1/*1 P P
P for variables was calculated using Chi-squared test.P for variables was calculated using multivariate ordinal logistic regression after adjusting for covariates, including gender, age, area and group.ALDH2: acetaldehyde dehydrogenase-2; HIA: high-incidence area; LIA: low-incidence area.
Gender0.3860.387
 Male69 (1.7)967 (24.5)2911 (73.8)
 Female50 (2.1)617 (25.6)1747 (72.4)
Age, years0.8520.989
 ≤ 6082 (1.8)1116 (25.1)3250 (73.1)
 >6037 (1.9)468 (24.5)1408 (73.6)
Area< 0.001< 0.001
 HIA55 (1.7)735 (22.8)2429 (75.5)
 LIA64 (2.0)849 (27.0)2229 (70.9)
Group0.2720.277
 Case48 (1.8)643 (23.9)1995 (74.3)
 Control71 (1.9)941 (25.6)2663 (72.5)
Distribution of the clinical variables according to theALDH2 genotype,n (%)

The association betweenALDH2 genotypes and GCA risk

Data from 3,675 controls and 2,686 GCA samples were used to evaluate the association between GCA risk andALDH2 genotypes. The ratio ofALDH2 2*2 and 1*2 genotypes in the GCA was slightly lower than that in control subjects (25.7%vs. 27.5%). However, univariate and multivariate analyses showed that the association between theALDH2 *2 allele and GCA risk in total was not significant (P>0.05) ( ).
2

Distribution of cases and controls with regard to theALDH2 genotype,n (%)

CaseControlCrude OR (95%CI)P Adjusted OR (95%CI)P
ALDH2*2/*2+*1/*2 ALDH2*1/*1 ALDH2*2/*2+*1/*2 ALDH2*1/*1
P: for variables was calculated using Chi-squared test.P: for variables was calculated using binary logistic regression after adjusting for covariates, including gender, age and area.ALDH2: acetaldehyde dehydrogenase-2; HIA: high-incidence area; LIA: low-incidence area.
Total691 (25.7)1995 (74.3)1012 (27.5)2663 (72.5)0.91 (0.81–1.02)0.1071.07 (0.95–1.22)0.271
Gender
 Male519 (24.9)1562 (75.1)517 (27.7)1349 (72.3)0.87 (0.75–1.00)0.0491.16 (0.99–1.35)0.061
 Female172 (28.4)433 (71.6)495 (27.4)1314 (72.6)1.05 (0.86–1.29)0.6120.92 (0.74–1.15)0.468
Age, years
 ≤60331 (25.2)983 (74.8)867 (27.7)2267 (72.3)0.88 (0.76–1.02)0.0901.10 (0.95–1.29)0.202
 >60360 (26.2)1012 (73.8)145 (26.8)396 (73.2)0.97 (0.78–1.22)0.8011.00 (0.79–1.26)0.978
Area
 HIA337 (23.7)1083 (76.3)453 (25.2)1346 (74.8)0.92 (0.79–1.09)0.3431.10 (0.93–1.32)0.275
 LIA354 (28.0)912 (72.0)559 (29.8)1317 (70.2)0.91 (0.78–1.07)0.2661.04 (0.87–1.25)0.658
Distribution of cases and controls with regard to theALDH2 genotype,n (%) In different subgroups, univariate analyses exhibited a weak difference forALDH2 genotypic distribution between cases, and control had no difference in males (24.9%vs. 27.7%,P=0.049). Furthermore, multivariate analysis showed that the association betweenALDH2 *2 allele and GCA risk in all subgroups was not significant (P>0.05) ( ).

Discussion

In this study, we demonstrate that rs671 variation is not associated with GCA risk. Further stratified analysis confirms that the ratio of ALDH2 2*2 and 1*2 genotypes in the GCA cases is not higher compared with that in control subjects among subgroups in terms of gender, age, or high- and low-incidence areas for both GCA and ESCC, while significant differences were found between the cases and controls in mean age and gender. These findings may be due to the nonexistent restrictions on age, gender, risk factor exposures or cancer stages in the case or control sample recruitments in our study and the peak age of 65 to 75, with men outnumbering women 2.5 to 1 for GCA patients in China[19] Considering that the high-incidence record for GCA is 25.58/100,000 in China[3], the researchers found that the maximum number of GCA patients estimated in the control group might be one case based on the current 3,675 control samples. Therefore, the controls should not confound the association of the risk for GCA with theALDH2 genotypes. Our GWAS confirmed that rs671 polymorphism withinALDH2 gene is not associated with the susceptibility of ESCC in the Chinese Han population[7]. The coincident results suggested that rs671 polymorphism may share a similar contribution in both esophageal and gastric cardia carcinogenesis in the Chinese Han population. The heterozygous or homozygous allele 504lys carrier has a reduced ability to remove acetaldehyde, which in turn leads to reduced ability for drinking[20,27]. According to Mendelian randomization, environmental exposure was determined by genetic variants, which should be associated with the disease risk[28]. Therefore,ALDH2 *1/*2 orALDH2 *2/*2 genotypes carrier has much lower capability to metabolize acetaldehyde, which greatly reduced the risk for alcohol exposure[20]. Drinking behavior could be regulated byALDH2 genotypes in the Japanese and Chinese populations[27,29]. In this study, the number of individuals in the GCA homozygous or heterozygous forALDH2 *2 was slightly lower than that in control subjects. This suggests that the consumption frequency of alcohol may be higher in the case group than in the control group, and the consumption of alcohol is associated with increased risk of GCA. This conjecture is consistent with the previous results[30,31]. In addition, we initially found that distribution ofALDH2 genotypes is different in Chinese Han cohorts between high- and low-incidence areas. The genetic background of residents from high- and low-incidence areas for both GCA and ESCC may be different. Previous reports including our GWAS studies show that alcohol drinking interacted withALDH2 (rs671) on ESCC susceptibility[7,32,33]. Owing to the similar underlying molecular mechanism involved in both GCA and ESCC, the researchers found that the rs671 variation might interact with alcohol consumptions on GCA susceptibility. Alcohol intakes vary widely in different regions of China. Thus, the different genotype distribution ofALDH2 and drinking consumptions of the residents may be one of the reasons why mortality rate of GCA varies greatly in high- and low-incidence areas for both GCA and ESCC. Limitations of this study: we were unable to further explore the interaction effects ofALDH2 genotypes and alcohol consumption on the risk for GCA because this data does not contain alcohol history. In conclusion, genotypes of rs671 atALDH2 are not involved in GCA susceptibility in the Chinese Han population. Interestingly, the frequency of homozygous or heterozygousALDH2 *2 carriers in the Chinese Han population in the high-incidence areas for both GCA and ESCC was lower than in the low-incidence areas, suggesting the possible genetic mechanism for the dramatic geographic difference of GCA occurrence in China.

Acknowledgements

This study was supported by grants from the National Natural Science Foundation of China (Grant No. 81472323), Top Talent Support Project of Zhengzhou University (Grant No. ZDGD 13001) and Innovation Scientists and Technicians Troop Construction Projects of Henan Province (Grant No. 3047).

Conflict of interest statement

No potential conflicts of interest are disclosed.
  32 in total

1.  Carcinogenetic impact of ADH1B and ALDH2 genes on squamous cell carcinoma risk of the esophagus with regard to the consumption of alcohol, tobacco and betel quid.

Authors:  Chien-Hung Lee; Jang-Ming Lee; Deng-Chyang Wu; Yih-Gang Goan; Shah-Hwa Chou; I-Chen Wu; Ein-Long Kao; Te-Fu Chan; Meng-Chuan Huang; Pei-Shih Chen; Chun-Ying Lee; Chia-Tsuan Huang; Hsiao-Ling Huang; Chih-Yang Hu; Yu-Hsiu Hung; Ming-Tsang Wu
Journal:  Int J Cancer       Date:  2008-03-15       Impact factor: 7.396

2.  Genetic polymorphisms in cytochrome P4502E1, alcohol and aldehyde dehydrogenases and the risk of esophageal squamous cell carcinoma in Gansu Chinese males.

Authors:  Yan-Mei Guo; Qin Wang; Yan-Zhen Liu; Huei-Min Chen; Zhi Qi; Qing-Hong Guo
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

3.  Distribution of ADH2 and ALDH2 genotypes in different populations.

Authors:  H W Goedde; D P Agarwal; G Fritze; D Meier-Tackmann; S Singh; G Beckmann; K Bhatia; L Z Chen; B Fang; R Lisker
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

4.  Confirmation of ALDH2 as a Major locus of drinking behavior and of its variants regulating multiple metabolic phenotypes in a Japanese population.

Authors:  Fumihiko Takeuchi; Masato Isono; Toru Nabika; Tomohiro Katsuya; Takao Sugiyama; Shuhei Yamaguchi; Shotai Kobayashi; Toshio Ogihara; Yukio Yamori; Akihiro Fujioka; Norihiro Kato
Journal:  Circ J       Date:  2011-03-01       Impact factor: 2.993

5.  Dietary patterns and risk of squamous-cell carcinoma and adenocarcinoma of the esophagus and adenocarcinoma of the gastric cardia: a population-based case-control study in Sweden.

Authors:  Shahram Bahmanyar; Weimin Ye
Journal:  Nutr Cancer       Date:  2006       Impact factor: 2.900

6.  Strong protective effect of the aldehyde dehydrogenase gene (ALDH2) 504lys (*2) allele against alcoholism and alcohol-induced medical diseases in Asians.

Authors:  Dawei Li; Hongyu Zhao; Joel Gelernter
Journal:  Hum Genet       Date:  2011-11-20       Impact factor: 4.132

7.  Single nucleotide polymorphisms of ADH1B, ADH1C and ALDH2 genes and esophageal cancer: a population-based case-control study in China.

Authors:  Ming Wu; Shen-Chih Chang; Ellen Kampman; Jie Yang; Xu-Shan Wang; Xiao-Ping Gu; Ren-Qiang Han; Ai-Min Liu; Gina Wallar; Jin-Yi Zhou; Frans J Kok; Jin-Kou Zhao; Zuo-Feng Zhang
Journal:  Int J Cancer       Date:  2012-09-28       Impact factor: 7.396

8.  Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles.

Authors:  Fumiaki Tanaka; Ken Yamamoto; Sadao Suzuki; Hiroshi Inoue; Masahiko Tsurumaru; Yoshiaki Kajiyama; Hoichi Kato; Hiroyasu Igaki; Koh Furuta; Hiromasa Fujita; Toshiaki Tanaka; Yoichi Tanaka; Yoshiyuki Kawashima; Shoji Natsugoe; Tetsuro Setoyama; Shinkan Tokudome; Koshi Mimori; Naotsugu Haraguchi; Hideshi Ishii; Masaki Mori
Journal:  Gut       Date:  2010-09-09       Impact factor: 23.059

9.  Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China.

Authors:  Gina D Tran; Xiu-Di Sun; Christian C Abnet; Jin-Hu Fan; Sanford M Dawsey; Zhi-Wei Dong; Steven D Mark; You-Lin Qiao; Philip R Taylor
Journal:  Int J Cancer       Date:  2005-01-20       Impact factor: 7.396

10.  Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China.

Authors:  Hong Chen; Li-Dong Wang; Mei Guo; She-Gan Gao; Hua-Qin Guo; Zong-Min Fan; Ji-Lin Li
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

View more
  6 in total

1.  Gastric cancer may share genetic predisposition with esophageal squamous cell carcinoma in Chinese populations.

Authors:  Linhua Yao; Fei Yu; Yingying Mao; Tianpei Wang; Qi Qi; Hui Ding; Jinchen Wang; Hongxia Ma; Juncheng Dai; Guoxin Zhang; Guangfu Jin
Journal:  J Hum Genet       Date:  2018-09-10       Impact factor: 3.172

2.  Association between ALDH2 rs671 G>A polymorphism and gastric cancer susceptibility in Eastern Asia.

Authors:  You Jiang; Jun Zhang; Yuee Wu; Jian Wang; Liang Li
Journal:  Oncotarget       Date:  2017-10-19

3.  Effect of ALDH2 polymorphism on cancer risk in Asians: A meta-analysis.

Authors:  Wei Zuo; Zhenyu Zhan; Lin Ma; Wei Bai; Shanggan Zeng
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

4.  Association between ALDH2 Polymorphism and Gastric Cancer Risk in a Korean Population.

Authors:  Chang Kyun Choi; Sun Seog Kweon; Sang Hee Cho; Hye Yeon Kim; Min Ho Shin
Journal:  J Korean Med Sci       Date:  2020-05-04       Impact factor: 2.153

5.  MicroRNA-320d regulates tumor growth and invasion by promoting FoxM1 and predicts poor outcome in gastric cardiac adenocarcinoma.

Authors:  Xiaojie Chen; Shegan Gao; Zhiwei Zhao; Gaofeng Liang; Jinyu Kong; Xiaoshan Feng
Journal:  Cell Biosci       Date:  2020-06-16       Impact factor: 7.133

Review 6.  Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease Pathogenesis.

Authors:  Qiaoling Wang; Binxia Chang; Xiaoyan Li; Zhengsheng Zou
Journal:  J Clin Transl Hepatol       Date:  2021-01-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.